Capabilities
Six questions a feasibility answer has to survive.
Rationale, Design, Cohort, Where & How, Commercial, Verdict — 30 named analyses across six pillars, each one cited to the public record it came from.
Six pillars compose into one go/no-go
The assessment
Every pillar answers one question — and shows its work.
A feasibility pack that cannot be checked is an opinion with formatting. Each pillar below states the analyses that actually run, what they need as input, and what they cannot tell you.
Pillar 1 of 6
Rationale
Should this drug work?
The scientific case for the asset, rebuilt from public target, pharmacology and structural evidence — so the biology is pressure-tested before a phase is spent on it.
Pillar 2 of 6
Design
Is the trial designed to win?
Your design against the indication norm — and against every comparable trial that failed or succeeded before you, with the design features that separated them.
Pillar 3 of 6
Cohort
Can you find the patients?
How many eligible patients exist, how much your own eligibility criteria shrink that pool, and how wide the honest range around the answer really is.
Pillar 4 of 6
Where & How
Where do you run it — and at what cost?
Sites and investigators on a map, ranked by track record and competition, with a budget band that is modelled rather than asserted.
Pillar 5 of 6
Commercial
Is it worth it if it works?
The commercial case behind the clinical one — market, price, standard of care and patent runway, each an explicit assumption you can move.
Pillar 6 of 6
Verdict
Go, or no-go?
Everything above composed into one recommendation — with the risks that could still change it, and an honest account of how confident the answer actually is.
How they compose
One verdict, not six reports
The pillars are not independent scores bolted together. Cohort constrains Design; Design and Cohort constrain Where & How; Commercial decides whether the whole thing is worth doing; Verdict composes all five and names the risks that could still flip it.
Every number is cited
Each figure carries the source record and the snapshot it was read from, so it can be re-checked months later — by you, a partner, or a regulator.
A gap is reported as a gap
An analysis that could not run says so. It never reports a missing input as a measured zero, because a confident wrong number is worse than an honest blank.
A human signs it off
Seven expert roles draft from these pillars; a qualified human reviews and signs. The sign-off is a 21 CFR Part 11 e-signature on a hash-chained record.
See a verdict you can actually check.
Send us a protocol — or just a molecule and an indication. We'll return a fully cited feasibility assessment you can trace, line by line, back to public data — yours to defend in a bid, take to your board or investment committee, or hand to a regulator.